SPASTICITY X 2027
Esta página aún no está disponible en tu idioma.
SPASTICITY X 2027, the 2nd International Symposium of the International Spasticity Society (ISS), takes place March 31–April 3, 2027, in Barcelona, Spain. Its focus is spasticity, with preliminary sessions explicitly addressing botulinum toxins alongside assessment, rehabilitation, and other interventions. Registration and abstract submission are open. (ISS symposium announcement 🔗, preliminary scientific program 🔗)
The symposium provides a focused meeting context for limb spasticity. It is separate from INA’s broader TOXINS conference and from the rehabilitation-wide AAPM&R Annual Assembly.
Event Snapshot
Section titled “Event Snapshot”| Field | Published information |
|---|---|
| Organizer | International Spasticity Society |
| Dates | March 31–April 3, 2027 |
| City | Barcelona, Spain |
| Headquarters hotel | Hyatt Regency Barcelona Tower, Avinguda de la Gran via, 144, L’Hospitalet de Llobregat, 08907 Barcelona, Spain |
| Program | Preliminary scientific program and separate schedule of events available; some timings differ |
| Registration | Open; early-bird period ends November 16, 2026 |
| Abstracts | Open for oral and poster consideration; deadline January 8, 2027, 11:59 p.m. Eastern Time |
The general information page 🔗 identifies the hotel as the symposium headquarters. Online participation and recording access have not been confirmed in the published registration information.
Botulinum Toxin Program
Section titled “Botulinum Toxin Program”The preliminary scientific program 🔗 includes dedicated toxin sessions and related contributions within the wider spasticity program:
| Date | Program area | Listed topics |
|---|---|---|
| April 1 | Early management, pediatric care, and patient perspectives | Early intervention, assessment of treatment outcomes, and adherence to toxin therapy |
| April 2 | Botulinum Toxins I | Gait, pain-related topics, sensory symptoms, and shoulder pain |
| April 3 | Botulinum Toxins II | Multiple treatment indications, duration-related topics, new research, and movement patterns |
| April 3 | Muscle-focused closing session | Research on muscle morphology, stiffness, growth, and contractile function |
These are scheduled discussion topics, not conclusions about efficacy, safety, dosing, or approved uses. A lecture title does not establish a product indication or comparative benefit.
The scientific program and the separate preliminary schedule of events 🔗 disagree on some opening-session and parallel-session timings and numbering. Exact session appointments require a reconciled final timetable. The registration form also retains a welcome-reception date of November 11, 2026, which conflicts with the announced March–April 2027 symposium; it should not determine travel dates.
Registration And Access
Section titled “Registration And Access”The registration information 🔗 lists scientific sessions, the exhibition and poster hall, reception, meals, and conference materials among the included activities. Hotel accommodation is separate. Its category table distinguishes an Industry Representative pass with scientific-session access from an Industry Exhibitor pass without session access; exhibition participation alone does not provide the same educational entitlement.
| Date | Registration milestone |
|---|---|
| November 16, 2026 | Early-bird registration ends |
| November 17, 2026 | Regular registration begins |
| March 19, 2027, 11:59 p.m. EDT | Published registration cutoff |
| March 31, 2027 | On-site registration begins |
The organizer lists both the March 19 cutoff and the later on-site opening. Confirm the applicable route and availability before relying on late registration. The 2027 registration form 🔗 is available, but its inconsistent reception date needs organizer clarification.
The EACCME information page 🔗 describes intended accreditation in future-tense language and does not give a confirmed credit total. Registration wording about credits does not establish a final accredited amount.
Abstract Submission
Section titled “Abstract Submission”The ISS abstract instructions 🔗 set a deadline of January 8, 2027, at 11:59 p.m. Eastern Time, with rolling review for oral and poster consideration. Corresponding authors are told to expect a response within six weeks; the committee determines acceptance and the final presentation format.
Submissions use the official abstract form 🔗. Previously presented work may be considered under the organizer’s encore rules. Authors may submit without attending, but accepted authors who do attend must register separately. Acceptance does not include a conference pass.
Exhibition And Sponsorship
Section titled “Exhibition And Sponsorship”The exhibition and sponsorship page 🔗 offers support tiers and a prospectus. The preliminary schedule includes an exhibition and industry-supported session slots, but those opportunities do not identify confirmed company sponsors or products. A named 2027 toxin-company exhibitor or sponsor list has not been confirmed in the public material reviewed.
An exhibitor, a sponsored-session host, a faculty affiliation, and a product named in a scientific presentation are different relationships. None alone establishes regulatory approval, availability, interchangeability, unit equivalence, or comparative clinical benefit. The societies and congresses overview places these records within the broader event landscape.

